Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
OXYCONTIN
Generic name / active ingredient
oxycodone hydrochloride extended-release tablets
Dosage-form class
Oxycodone hydrochloride film-coated extended-release tablets; must be swallowed whole. Do not cut, break, chew, crush or dissolve. Immediate-release oxycodone, oxycodone/acetaminophen combinations, another oxycodone extended-release capsule and the historical original formulation are not merged into this dossier.
Route
Oral; must be swallowed whole (higher-risk extended-release product-identity field)
Record reviewed
2026-08-30

Copy from the pack in hand

Source-linked reading points

  • OXYCONTIN is an extended-release tablet and must be swallowed whole. Cutting, breaking, chewing, crushing or dissolving can defeat the controlled release and expose a person to a potentially fatal oxycodone dose; the label does not describe a self-splitting score. If swallowing is difficult, do not alter the tablet—contact the prescriber or pharmacist.
  • Serious, life-threatening or fatal respiratory depression can occur and requires particular professional monitoring after initiation or change. Older, frail people, those with chronic lung disease or reduced respiratory reserve, and anyone with unusual sleepiness, difficulty waking, slow or shallow breathing, blue lips or altered consciousness need priority attention; severe signs require local emergency services immediately.
  • Benzodiazepine sleeping/anxiety medicines, other sedative-hypnotics, other opioids, anaesthetics, some antipsychotics, gabapentinoids and alcohol can increase profound sedation, respiratory depression, coma and death when present with OXYCONTIN. Separating clock times does not establish safety; place every prescription, OTC medicine, alcohol exposure and supplement on one list for a clinician or pharmacist.
  • The label restricts 60 mg, 80 mg and certain higher-exposure situations to people with established opioid tolerance. Prior pain-medicine use, body weight, a pain score or leftover tablets cannot let a webpage establish tolerance; do not self-escalate strength, convert another opioid or use another person's medicine.

Reviewed presentation examples — compare every field

  • Oxycodone hydrochloride 10 mg per tablet; 100-tablet child-resistant bottleNDC 59011-410-10
  • Oxycodone hydrochloride 15 mg per tablet; 100-tablet child-resistant bottleNDC 59011-415-10
  • Oxycodone hydrochloride 20 mg per tablet; 100-tablet child-resistant bottleNDC 59011-420-10
  • Oxycodone hydrochloride 30 mg per tablet; 100-tablet child-resistant bottleNDC 59011-430-10
  • Oxycodone hydrochloride 40 mg per tablet; 100-tablet child-resistant bottleNDC 59011-440-10
  • Oxycodone hydrochloride 60 mg per tablet; 100-tablet child-resistant bottle; label states for opioid-tolerant patients onlyNDC 59011-460-10
  • Oxycodone hydrochloride 80 mg per tablet; 100-tablet child-resistant bottle; label states for opioid-tolerant patients onlyNDC 59011-480-10

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-30
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image